UNILABS A/S: Financial statements 2023
CVR: 29458219
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
UNILABS A/S (CVR 29458219) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 70,149,000 and a net result of DKK 27,652,000 compared with DKK 18,190,000 the year before. That is an increase of 3.5% compared with the year before. Equity in the 2023 report amounted to DKK 167,731,000. The solvency ratio was 77%. The company had 46 employees in the financial year.
- Gross Profit
- DKK 70,149,000
- Profit/Loss
- DKK 27,652,000
- Equity
- DKK 167,731,000
- Total Assets
- DKK 217,789,000
- Employees
- 46
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 70.1 mio. | 27.7 mio. | 167.7 mio. | 46 |
| 2022 | - | 67.8 mio. | 18.2 mio. | 140.1 mio. | 48 |
| 2021 | - | 59.9 mio. | 16.1 mio. | 121.9 mio. | 55 |
| 2020 | - | 50 mio. | 9.3 mio. | 105.8 mio. | 59 |
| 2019 | - | 53.6 mio. | 12.1 mio. | 96.5 mio. | 80 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 11, 2023, Thomas Axel Per Lindahl has joined the board of directors of UNILABS A/S.
As of December 11, 2023, Christian Peter Rebhan has left the board of directors of UNILABS A/S.
UNILABS A/S has published its annual report for 2022. Gross profit came to DKK 67,790,000, and the net result was DKK 18,190,000.
As of February 9, 2023, Christian Peter Rebhan has joined the board of directors of UNILABS A/S.
As of February 9, 2023, Lars Linaa Jørgensen has left the board of directors of UNILABS A/S.
About UNILABS A/S
UNILABS A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named CAPIO DIAGNOSTIK A/S and NOVA MEDICAL MEDI-LAB A/S. The management consists of Amar Rauf. The board consists of Thomas Axel Per Lindahl (chair), Amar Rauf and Eric Schuh. The company is owned by Unilabs Laboratoire d'Analyses Médicales SA. The company has 47 employees (2026). In 2025, the company reported a gross profit of DKK 74,330,000 and a net result of DKK 37,726,000 compared with DKK 44,593,000 the year before. Equity in the 2025 report amounted to DKK 90,050,000.